Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 May;57(9):962-978.
doi: 10.1111/apt.17466. Epub 2023 Mar 14.

Review article: An analysis of the pharmacological rationale for selecting drugs to inhibit vomiting or increase gastric emptying during treatment of gastroparesis

Gareth J Sanger  1 , Paul L R Andrews  2
Affiliations
Review

Review article: An analysis of the pharmacological rationale for selecting drugs to inhibit vomiting or increase gastric emptying during treatment of gastroparesis

Gareth J Sanger et al. Aliment Pharmacol Ther. 2023 May.

Abstract

Background: Drugs which can inhibit nausea/vomiting and/or increase gastric emptying are used to treat gastroparesis, mostly 'off-label'. Within each category, they act at different targets and modulate different physiological mechanisms.

Aims: Address the questions: In gastroparesis, why should blocking one pathway causing vomiting, be more appropriate than another? Why might increasing gastric emptying via one mechanism be more appropriate than another?

Methods: Drugs used clinically were identified via consensus opinions and reviews, excluding the poorly characterised. Their pharmacology was defined, mapped to mechanisms influencing vomiting and gastric emptying, and rationale developed for therapeutic use.

Results: Vomiting: Rationale for 5-HT3 , D2 , H1 or muscarinic antagonists, and mirtazapine, amitriptyline, nortriptyline, are poor. Arguments for inhibiting central consequences of vagal afferent transmission by NK1 antagonism are complicated by doubts over effects on nausea. Gastric emptying: Confusion emerges because of side-effects of drugs increasing gastric emptying: Metoclopramide (5-HT4 agonist, D2 and 5-HT3 antagonist; also blocks some emetic stimuli and causes tardive dyskinesia) and Erythromycin (high-efficacy motilin agonist, requiring low doses to minimise side-effects). Limited trials with selective 5-HT4 agonists indicate variable efficacy.

Conclusions: Several drug classes inhibiting vomiting have no scientific rationale. NK1 antagonism has rationale but complicated by limited efficacy against nausea. Studies must resolve variable efficacy of selective 5-HT4 agonists and apparent superiority over motilin agonists. Overall, lack of robust activity indicates a need for novel approaches targeting nausea (e.g., modulating gastric pacemaker or vagal activity, use of receptor agonists or new targets such as GDF15) and objective assessments of nausea.

Keywords: aprepitant; domperidone; gastric emptying; gastroparesis; nausea; prucalopride; vomiting.

PubMed Disclaimer

Comment in

References

REFERENCES

    1. Schol J, Wauters L, Dickman R, Drug V, Mulak A, Serra J, et al. United European gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis United European Gastroenterol J 2021;9:287-306.
    1. Camilleri M, Dilmaghani S, Vosoughi K, Zheng T. A north American perspective on the ESNM consensus statement on gastroparesis. Neurogastroenterol Motil. 2021;38:e14174.
    1. Silver PJ, Dadparvar S, Maurer AH, Parkman HP. Proximal and distal intragastric meal distribution during gastric emptying scintigraphy: relationships to symptoms of gastroparesis. Neurogastroenterol Motil. 2022;34:e14436. https://doi.org/10.1111/nmo.14436
    1. Lee K-J, Vos R, Janssens J, Tack J. Differences in the sensorimotor response to distension between the proximal and distal stomach in humans. Gut. 2004;53:938-43.
    1. Jalleh RJ, Jones KL, Rayner CK, Marathe CS, Wu T, Horowitz M. Normal and disordered gastric emptying in diabetes: recent insights into (patho)physiology, management and impact on glycaemic control. Diabetologia. 2022;65:1981-93.

Publication types

LinkOut - more resources